Artigo - Atena Editora

Artigo

Baixe agora

Livros
capa do ebook THE USE OF COMBINED HORMONAL CONTRACEPTIVES AND OCCURRENCE OF METABOLIC SYNDROME: A NARRATIVE REVISION

THE USE OF COMBINED HORMONAL CONTRACEPTIVES AND OCCURRENCE OF METABOLIC SYNDROME: A NARRATIVE REVISION

Objective: The goal of this revision is to explain if the use of combined hormonal contraceptives (CHCs) can be correlated to metabolic alterations that may have an association on the occurrence of  metabolic syndrome. Methods: Articles published between January 2008 and September 2020 identified in Google Scholar, Scielo, Pubmed, and Cochrane databases were enlisted and narrowed down to 28 selected articles and one Ph.D. thesis. Results: The use of CHCs may influence carbohydrate metabolism, lipid profile, and changes in C-reactive protein (CRP), however, the influence of CHCs on abdominal circumference, blood pressure, and the prevalence of metabolic syndrome is unclear. Conclusions: The results found were controversial in most of the investigated cases of metabolic alterations. Therefore, there is no association between the use of CHCs and the occurrence of metabolic syndrome. 

Ler mais

THE USE OF COMBINED HORMONAL CONTRACEPTIVES AND OCCURRENCE OF METABOLIC SYNDROME: A NARRATIVE REVISION

  • DOI: 10.22533/at.ed.1592110117

  • Palavras-chave: Metabolic syndrome, contraceptives, metabolism.

  • Keywords: Metabolic syndrome, contraceptives, metabolism

  • Abstract:

    Objective: The goal of this review is to explain if the use of combined hormonal contraceptives (CHCs) can be correlated to metabolic alterations that may have an association on the occurrence of  metabolic syndrome.

    Methods: Articles published between January 2008 and September 2020 identified in Google Scholar, Scielo, Pubmed, and Cochrane databases were enlisted and narrowed down to 28 selected articles and one Ph.D. thesis.

    Results: The use of CHCs may influence carbohydrate metabolism, lipid profile, and changes in C-reactive protein (CRP), however, the influence of CHCs on abdominal circumference, blood pressure, and the prevalence of metabolic syndrome is unclear.

    Conclusions: The results found were controversial in most of the investigated cases of metabolic alterations. Therefore, there is no association between the use of CHCs and the occurrence of metabolic syndrome.

  • Número de páginas: 15

  • Francisco das Chagas Medeiros
  • Jose Juvenal Linhares
  • Liana Gonçalves Aragão Rocha
  • Aline Felismino Lima
  • Antonio Lucas Albuquerque Sabóia
  • Carla Roberta Macedo de Sousa
Fale conosco Whatsapp